Back to Search Start Over

Supplemental Table 1 from Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers

Authors :
Matthew D. Hellmann
Helena Yu
Gregory J. Riely
Marc Ladanyi
Maria E. Arcila
Nikolaus Schultz
Charles M. Rudin
Mark G. Kris
Alexander Drilon
Bob T. Li
Francisco Sanchez-Vega
Andy Ni
Megan Tenet
Hira Rizvi
Michael Offin
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Full annotated cohort of EGFR-mutant lung cancer patients evaluated (n = 153)

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....4491a9bf2e35633853c3b496ce62effa
Full Text :
https://doi.org/10.1158/1078-0432.22469036.v1